Group 1 - The report by Han Kun Law Firm indicates that early-stage investment projects continue to grow, with seed, angel, and Pre-A rounds accounting for 44.04% of all VC/PE projects in 2024, the highest proportion in nearly eight years [1] - The proportion of domestic structure projects has increased significantly, with 73.58% of VC/PE projects adopting domestic structures in 2024, marking the highest level in nearly eight years [1] - The primary operational locations for invested companies remain concentrated in Beijing, Shanghai, and Shenzhen, which together account for 53.37% of all VC/PE projects in 2024 [1] Group 2 - The hottest investment sectors in 2024 are artificial intelligence and biomedicine, with AI software projects making up 18.65% and smart hardware projects 7.25%, totaling 25.90% [2] - The biotechnology, medical, and pharmaceutical sectors attracted 21.24% of the total VC/PE projects in 2024 [2]

Group 1 - The Q Bay Center 2025 annual event in Hangzhou focused on cutting-edge fields such as biotechnology, intelligent manufacturing, cross-border e-commerce, and AI technology, showcasing the innovation vitality in Qiantang [1] - Ten overseas projects from the fields of biomedicine and artificial intelligence presented their technological innovations, market prospects, domestic demand, and financing needs during the project roadshow [1] - Intuitive Autonomy's CEO expressed interest in establishing a Chinese headquarters in Hangzhou, highlighting the region's complete intelligent manufacturing industry chain and favorable business environment [1] Group 2 - Qiantang has concentrated on five leading industries, including "automobile, medicine, chips, and aviation," and has increased efforts to attract and cultivate high-level talent projects [2] - As of now, Qiantang has gathered 78 Fortune Global 500 projects and 1,810 foreign-funded enterprises, forming a comprehensive industrial ecosystem [2] - Future plans include building broader and smoother bridges for the landing of technology projects and talent-technology exchanges, promoting capital connections and deep cooperation across various fields [2]

Core Insights - China holds over 60% of the global rare earth mineral production and has a near-monopoly in the rare earth processing sector, which is crucial for high-tech manufacturing and now for advancements in artificial retina technology [1] - Researchers have developed an artificial retina using tellurium, a mineral primarily sourced from China, which not only restored vision in blind animals but also granted them "super vision" to see infrared light, presenting significant hope for human blindness treatment [1][2] Group 1 - The artificial retina was created using tellurium nanowires, which were implanted in genetically blind mice and monkeys, restoring their vision and enabling them to detect "invisible" light [1][2] - Tellurium, a byproduct of copper refining, is rare and has excellent optoelectronic properties, making it suitable for applications in semiconductors, thermoelectric cooling, solar cells, and infrared detection [1] - The research team utilized chemical deposition techniques to create a network of 150-nanometer tellurium nanowires, which served as a retinal nanostructure, successfully restoring the pupillary reflex in blind mice and stimulating visual cortex activity [2] Group 2 - The implanted devices showed no complications, and the treated mice began to regain normal vision the day after surgery, demonstrating enhanced performance in pattern recognition and light source localization compared to untreated blind mice [2] - The tellurium nanowire implants were also tested in normal monkeys, where they increased sensitivity to near-infrared light, confirming the safety and biocompatibility of the implants [2] - The method developed by researchers has the potential to create a new generation of devices that convert light into neural stimulation signals, aiding many blind individuals in regaining limited but useful vision [3]

更多智能制造产业资讯 …… 扫码订阅 智能制造 产业日报， 精选行业新闻，帮你省时间！ 1. 【SpaceX龙飞船替代品难产：NASA推迟波音星际客机试飞】6月7日消息，据报道，美国宇航局 (NASA)已将波音公司问题重重的"星际客机"飞船的下一次最早可能飞行时间推迟至2026年，延后了 它的正式服役时间。该飞船原本被作为埃隆·马斯克(Elon Musk)旗下SpaceX"龙"飞船的替代方案。 NASA此前曾表示，星际客机下一次飞往国际空间站的任务最早可能在今年年底进行。然而，NASA 现在表示，目前仍在评估这次飞行任务是搭载宇航员，还是仅运送货物。（凤凰科技） O AIGC 产业动态日报 谷歌宣布在医疗保健领域推出人工智能计划 并致力于打造/ Stability Al发布3D视频生成工具SV3D! 可 同时输出多个新视角 这款新模型基于Stable Video Diff on模型的改讲,留 移根据单一辑入图像创建和转换多视图3D网格。 2. 【长三角先进制造业集群联盟揭牌成立】6月7日消息，在第七届长三角一体化发展高层论坛上， 三省一市经（工）信部门共同为长三角先进制造业集群联盟揭牌，沪苏浙皖共谋科技创新和 ...

Group 1 - During the week of May 19 to May 25, four new IPO applications were accepted by the Shanghai and Shenzhen stock exchanges, while one application was terminated [1][2] - The four companies include Changyu Group applying for the Shanghai main board, Shenglong Mining Group for the Shenzhen main board, and Peicheng Technology and Kanghua Biomedical Technology for the Beijing Stock Exchange [1][2] - The terminated application was from Jiayuan Technology, which had been under review for nearly two years before withdrawing [1][5] Group 2 - Peicheng Technology, which specializes in battery management systems, reported a declining revenue trend from 850 million yuan in 2022 to 733 million yuan in 2024 [3] - The company's net profit also showed a decrease, with figures of 92.42 million yuan in 2022 and 93.44 million yuan in 2024 [3] - Peicheng Technology's gross margin decreased from 30.06% in 2022 to 28.57% in 2024, indicating potential risks related to product revenue structure changes [3] Group 3 - Jiayuan Technology's revenue heavily relies on State Grid, with sales to the company accounting for approximately 70% of its total revenue [5][6] - The company's revenue figures were 248 million yuan in 2020, 528 million yuan in 2021, and 581 million yuan in 2022, showing a slowdown in growth [6] - Jiayuan Technology faces risks related to the iteration of its smart terminal products and the pace of its digital solution implementations [7][8]

Financial Performance - In 2024, the company achieved a revenue of approximately 28.601 billion CNY, a year-on-year increase of 17.32% [1] - The net profit attributable to shareholders was 699 million CNY, a decrease of 4.97% compared to the previous year [1] - The refrigerator business generated approximately 9.296 billion CNY in revenue, growing by about 5.53% [2] - The air conditioning business reported revenue of approximately 15.407 billion CNY, an increase of about 33.20% [3] - The washing machine segment achieved revenue of approximately 1.747 billion CNY, up by about 31.44% [5] - The kitchen and small appliances sector saw revenue of approximately 1.492 billion CNY, a decrease of about 19.34% [5] - The biomedical business generated approximately 264 million CNY, down by about 5.36% [6] Market Strategies Domestic Market - The refrigerator sector focuses on enhancing customer service and product quality, emphasizing a "customer-centric" approach [1][10] - The air conditioning strategy includes promoting new products and enhancing brand influence through event marketing [3][13] - The washing machine strategy aims for high-end product development and channel transformation to increase market share [4][14] Overseas Market - The refrigerator business is expanding by introducing high-end products and targeting emerging markets [2][12] - The air conditioning segment is focused on brand development and expanding into new markets while maintaining quality [3][13] - The biomedical sector is enhancing customer service and expanding into new markets to solidify its overseas presence [6][12] Future Plans - In 2025, the company aims for dual growth in scale and profit, focusing on innovation and digital transformation [9] - The domestic refrigerator strategy will leverage customer needs and optimize channel operations for better profitability [10] - The overseas strategy will emphasize product differentiation and enhancing customer relationships to boost market share [12]

4月29日，南京新百（600682）发布2024年年度报告，公司报告期内实现营业收入67.00亿元，同比上涨 1.98%，归属于上市公司股东的净利润2.30亿元。公司同时发布的2025年一季报显示，1—3月实现营收 15.69亿元，归属于上市公司股东的净利润1.29亿元。南京新百大健康业务仍占主导地位，2024全年持续 稳健增长，并披露了2024年度ESG报告，坚持可持续高质量发展。 生物医疗方面，2024年，齐鲁干细胞继续实施多元化发展策略，在现有的脐血干细胞保存服务基础上持 续创新推出多室保存服务，以及包括免疫细胞储存和检测在内的多样化产品与服务；公司全资子公司济 南科阅医学检验实验室有限公司开展健康与衰老评估、AD检测等项目，并在深圳设立了深圳卓元干细 胞工程有限公司，扩大业务范围。2024年，齐鲁干细胞全力推进国际细胞治疗认证基金会FACT认证， 并已于2025年2月成为国内首家获得FACT国际认证的细胞机构。这一里程碑标志着齐鲁干细胞的技术实 力与质量管理体系跻身全球领先行列，也意味着我国细胞治疗领域迈入国际标准化新阶段。 2024年，丹瑞美国不断强化PROVENGE作为早期无症状或轻微症状的mCR ...

Group 1: Industry Development and Innovation - The Chinese government emphasizes the importance of integrating innovation chains, industrial chains, financial chains, and talent chains to accelerate the transformation of technological achievements into productive forces [1] - Wuhan is focusing on developing new productive forces by establishing 16 industrial chains, with private enterprises playing a dual role as "chain leaders" and "key supporters" [1] - Companies like Huazhong CNC, Dinglong Holdings, and Chipking Technology are leading the charge in their respective fields, contributing to the formation of a collaborative innovation ecosystem in Wuhan [1] Group 2: Chip Industry - Chipking Technology has successfully mass-produced China's first 7nm automotive-grade intelligent cockpit chip, "Longying No. 1," and is leading the domestic market in this segment [3][4] - The company is also developing the "Xingchen No. 1" chip for advanced driver assistance systems, which is expected to be mass-produced this year and widely adopted by 2026 [3][4] - Chipking Technology is building a self-controlled automotive chip supply chain by collaborating with upstream and downstream partners [2][4] Group 3: Semiconductor Materials - Dinglong Holdings specializes in providing critical materials for semiconductor manufacturing, including CMP polishing pads and photoresists, and has become a key player in the global semiconductor materials supply chain [9][11] - The company has successfully reduced the delivery cycle of its products to 3-4 weeks, supporting the large-scale production of integrated circuits [10][12] - Dinglong Holdings is leading the establishment of the "Wuhan Advanced Functional Materials Industry Innovation Joint Laboratory" to focus on the research and development of advanced functional materials [12] Group 4: Advanced Manufacturing - Huazhong CNC has launched the "Huazhong No. 10" intelligent CNC system, which integrates AI technology to enhance manufacturing efficiency and product quality [19][20] - The company is collaborating with local enterprises to develop high-end CNC systems and is part of a joint laboratory aimed at advancing core technologies in this field [21] - The joint laboratory is expected to become a leading platform for high-end CNC system research and development, promoting the transformation and upgrading of Wuhan's high-end manufacturing industry [21] Group 5: Life Sciences Innovation - Aibotai has upgraded its role to a life sciences innovation hub, supporting 12 high-end life science instrument companies and focusing on technology and product recognition [25][26] - The company has successfully incubated innovative products in the cardiovascular field, with plans for market launch this year [26] - Aibotai aims to leverage Wuhan's strong educational and industrial foundation to become a leading center for life sciences innovation [26]